- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 473/32 - Nitrogen atom
Patent holdings for IPC class C07D 473/32
Total number of patents in this class: 251
10-year publication summary
|
18
|
20
|
19
|
17
|
9
|
28
|
12
|
20
|
10
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Signal Pharmaceuticals, LLC | 186 |
21 |
| Chengdu Baiyu Pharmaceutical Co., Ltd. | 75 |
9 |
| Boehringer Ingelheim International GmbH | 4754 |
8 |
| Celgene Corporation | 1468 |
8 |
| CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 177 |
6 |
| AstraZeneca AB | 2958 |
5 |
| Takeda Pharmaceutical Company Limited | 2943 |
5 |
| Neupharma, Inc. | 73 |
5 |
| Pharmacopeia, Inc. | 32 |
5 |
| S*BIO Pte Ltd. | 28 |
5 |
| The Regents of the University of California | 19517 |
4 |
| Board of Regents, The University of Texas System | 5619 |
4 |
| Cancer Research Technology Limited | 525 |
4 |
| Incyte Holdings Corporation | 650 |
4 |
| Research Triangle Institute | 408 |
4 |
| F. Hoffmann-La Roche AG | 7942 |
3 |
| Wyeth LLC | 671 |
3 |
| Purdue Research Foundation | 3477 |
3 |
| Ildong Pharmaceutical Co., Ltd. | 93 |
3 |
| Acea Therapeutics, Inc. | 27 |
3 |
| Other owners | 139 |